BCR - C.R. Bard, Inc.

NYSE - NYSE Delayed Price. Currency in USD

0.00

0.00 (0.00%)

At close: 7:00PM EST

Stock chart is not supported by your current browser

Previous Close	0.00
Open	0.00
Bid	0.00 x 0
Ask	0.00 x 0
Day's Range	0.00 - 0.00
52 Week Range
Volume	0
Avg. Volume	N/A

Market Cap	N/A
Beta	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Trade prices are not sourced from all markets

All

News

Press Releases

Moody's2 months ago
Moody's: Outlook for US medical products and devices industry changed to positive
The outlook for the US medical products and devices industry has been revised upward, to positive from stable, Moody's Investors Service says in a just-published report. Continued product innovation and ...
Motley Fool3 months ago
Becton, Dickinson Ready to Sing a New Song
The addition of Bard will start paying off this year.
Benzinga4 months ago
KeyBanc Initiates Becton, Dickinson And Co. With Bullish Stance
Becton Dickinson and Co (NYSE: BDX ) was initiated with a top-notch rating by KeyBanc Capital Markets Thursday. The Analyst KeyBanc analyst Matthew Mishan initiated coverage on Becton Dickinson with an ...
Moody's4 months ago
C.R. Bard, Inc. -- Moody's withdraws C.R. Bard's ratings
Rating Action: Moody's withdraws C.R. Global Credit Research- 02 Jan 2018. New York, January 02, 2018-- Moody's Investors Service, withdrew the Baa1 senior unsecured and Prime-2 short term ratings of C.R....
Market Realist4 months ago
BD Gets Final Regulatory Approval for Bard Acquisition
On December 28, Becton, Dickinson and Company (BDX), or BD, received clearance for its Bard (BCR) acquisition form MOFCOM (Ministry of Commerce of the People's Republic of China), but the approval is contingent ...
Capital Cube4 months ago
ETFs with exposure to C.R. Bard, Inc. (New Jersey) : December 29, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to C.R. Bard, Inc. (New Jersey) Here are 5 ETFs with the largest exposure to BCR-US. Comparing the performance and risk of C.R. Bard, Inc. (New Jersey) with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)
PR Newswire4 months ago
BD Completes Bard Acquisition, Creating New Global Health Care Leader
FRANKLIN LAKES, N.J., Dec. 29, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (BCR), creating a new health care industry leader with approximately $16 billion in annualized revenue. The combined company is uniquely positioned to improve both the treatment of disease for patients and the process of care for health care providers. Additionally, Bard's strong product portfolio and innovation pipeline will increase BD's opportunities in fast-growing clinical areas, and the combination will enhance growth opportunities for the combined company in non-U.S. markets.
Zacks4 months ago
Becton, Dickinson (BDX), Bard Receive Regulatory Nod in China
Favorable tidings on the regulatory front have boosted Becton, Dickinson and Company (BDX) lately. After the closure of the deal, the company will establish a new business segment.
PR Newswire4 months ago
Huntington Ingalls Industries Set to Join S&P 500; Scientific Games to Join S&P MidCap 400 and Ultra Clean Holdings to Join S&P SmallCap 600
NEW YORK , Dec. 28, 2017 /PRNewswire/ -- S&P MidCap 400 constituent Huntington Ingalls Industries Inc. (NYSE: HII) will replace C. R. Bard Inc. (NYSE: BCR) in the S&P 500, S&P SmallCap 600 constituent ...
Moody's4 months ago
Becton, Dickinson and Company -- Moody's downgrades Becton, Dickinson and Company to speculative grade
Rating Action: Moody's downgrades Becton, Dickinson and Company to speculative grade. Global Credit Research- 28 Dec 2017. New York, December 28, 2017-- Moody's Investors Service, today downgraded Becton, ...
Zacks4 months ago
NutriSystem (NTRI) Adopts Multi-Brand Strategy for 2018
NutriSystem's (NTRI) Turbo Plans and South Beach Diet likely to witness an increase in customers.
PR Newswire4 months ago
BD Statement On MOFCOM Clearance Of Bard Acquisition
FRANKLIN LAKES, N.J. , Dec. 28, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's clearance ...
Zacks4 months ago
Becton, Dickinson (BDX) a Step Closer to Bard Acquisition
Becton, Dickinson and Company (BDX) gets FTC's nod for the acquisition of C. R. Bard.
Capital Cube4 months ago
C.R. Bard, Inc. (New Jersey) – Value Analysis (NYSE:BCR) : December 26, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives C.R. Bard, Inc. (New Jersey) a score of 81. Our analysis is based on comparing C.R. Bard, Inc. (New Jersey) with the following peers – Boston Scientific Corporation, Teleflex Incorporated, Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., Medtronic plc, CryoLife, Inc., Hologic, Inc. and ... Read more (Read more...)
PR Newswire4 months ago
BD Statement On FTC Clearance Of Bard Acquisition
FRANKLIN LAKES, N.J. , Dec. 22, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's clearance ...
Capital Cube4 months ago
ETFs with exposure to C.R. Bard, Inc. (New Jersey) : December 18, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to C.R. Bard, Inc. (New Jersey) Here are 5 ETFs with the largest exposure to BCR-US. Comparing the performance and risk of C.R. Bard, Inc. (New Jersey) with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)
Zacks4 months ago
Becton, Dickinson Banks on Bard Buyout, Medical Unit Weak
Becton, Dickinson (BDX) is steadily progressing with the acquisition of C. R. Bard. However, sluggishness in the Medical Segment is a headwind.
Capital Cube5 months ago
C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : December 08th, 2017 (record date) : By the numbers : December 8, 2017
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing C.R. Bard, Inc. (New Jersey) with the following peers – Boston Scientific Corporation, Teleflex Incorporated, Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., Medtronic plc, CryoLife, Inc., Hologic, Inc. and CONMED Corporation (BSX-US, TFX-US, BDX-US, ANGO-US, MMSI-US, MDT-US, CRY-US, HOLX-US and CNMD-US). C.R. ... Read more (Read more...)
Simply Wall St.5 months ago
How Does C R Bard Inc’s (BCR) EPS Growth Stack Up Against Industry Performance?
When C R Bard Inc (NYSE:BCR) released its most recent earnings update (30 September 2017), I compared it against two factor: its historical earnings track record, and the performance ofRead More...
American City Business Journals5 months ago
What Jabil's new director signals about the company's future
Jabil Inc. has tapped a health care industry financial expert for a soon-to-be-vacant seat on its board of directors. Christopher Holland, senior vice president and chief financial officer of C.R. Bard Inc., was nominated to stand for election to the Jabil board in January, a press release said. C.R. Bard (BCR) is a Murray Hill, New Jersey-based medical technology firm.
Capital Cube5 months ago
ETFs with exposure to C.R. Bard, Inc. (New Jersey) : November 27, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to C.R. Bard, Inc. (New Jersey) Here are 5 ETFs with the largest exposure to BCR-US. Comparing the performance and risk of C.R. Bard, Inc. (New Jersey) with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)
Motley Fool5 months ago
3 Top Diabetes Stocks to Buy Now
The diabetes market is growing. And these stocks are poised to grow with it.